
17 February 2025
Fevertree Drinks plc
("Fever-Tree" or the "Company")
Commencement of share buyback programme
Fever-Tree today announces the commencement of a share buyback programme regarding the purchase of ordinary shares in the Company with a nominal value of 0.25 pence each (the "Shares") up to a maximum consideration of £71 million (the "Programme").
Fever-Tree previously announced its intention to commence the Programme on 30 January 2025, alongside the announcement its strategic partnership with Molson Coors for the exclusive sales, distribution and production of the Fever-Tree brand in the US.
Fever-Tree has entered into a non-discretionary agreement with Investec Bank plc ("Investec") to purchase Shares on its behalf and to make trading decisions independently of the Company. The Programme will commence today, 17 February 2025, and end no later than 30 September 2025. The sole purpose of the Programme is to reduce the share capital of Fever-Tree. As such, the Company intends to cancel any Shares purchased.
Investec will purchase the Shares as principal and simultaneously be deemed to execute sales to the Company of any Shares so purchased in accordance with the terms of their engagement.
Any purchase of Shares under the Programme will be executed in accordance with certain pre-set parameters and in accordance with the Company's existing general authority to repurchase Shares granted by its shareholders at the annual general meeting held on 6 June 2024 (which permits the Company to purchase no more than 11,668,664 Shares), the Market Abuse Regulation (596/2014) as it forms part of domestic law by virtue of section 3 of the European Union (Withdrawal) Act 2018 (as amended) and UKLR 9.6.2 using the average daily volume of Ordinary Shares traded in January 2025, being the month preceding the month of this announcement. The Company may repurchase up to 25% of this average daily volume per day during the programme.
For further information:
Fever-Tree
Investor queries
Ann Morris-Gibbons, Director of Investor Relations I ann.hyams@fever-tree.com I +44 (0)7435 828 138
Media queries
Oliver Winters, Director of Communications I oliver.winters@fever-tree.com I +44 (0)770 332 9024
Nominated Advisor and Broker - Investec Bank plc
David Flin I +44 (0)20 7597 5970
Financial Adviser & Corporate Broker - Morgan Stanley & Co. International plc
Henry Stewart I Andrew Foster I Jessica Pauley I +44 (0)20 7425 8000
Corporate Broker - Jefferies International Limited
Ed Matthews I Richard Taylor I +44 (0)20 7029 8000
Financial PR advisers - FGS Global
Faeth Birch +44 (0)7768 943 171; Anjali Unnikrishnan +44 (0) 7826 534 233
About Fever-Tree:
Fever-Tree is the world's leading supplier of premium carbonated mixers for alcoholic spirits by retail sales value, with distribution to over 90 countries worldwide. Based in the UK, the brand was launched in 2005 to provide high quality mixers which could cater to the growing demand for premium spirits, in particular gin, but also increasingly for vodka, rum and whisky. The Company sells a range of carbonated mixers to hotels, restaurants, bars and cafes ("On Trade") as well as selected retail outlets ("Off Trade").
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.